A position paper recently published by the National Pulmonary Embolism Response Team outlines an approach for diagnosing and treating pulmonary embolism in patients with COVID-19.
Artificial intelligence has the potential to ease the workload of physicians while increasing the speed and accuracy of diagnosis, particularly in pulmonology.
The designation was based on results from Part A of a double-blind, placebo-controlled, pivotal phase 3 trial.
Children with lower birth size and slower body mass index gain in early childhood have lower lung function at 7 years.
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
The surgical management of patients with massive pulmonary embolism and high-risk submassive PE was found to be safe and highly effective for achieving right ventricular recovery.
One potential driver of high antibiotic prescribing rates for acute respiratory infections is patient’s prior care experiences.
Early sleep fragmentation, estimated by actigraphy, was found to be associated with worse cognitive impairment shortly after critical illness.
Emergency department visits for acute respiratory illness increased days before major thunderstorms, particularly in patients with asthma and COPD.
Regardless of the type of trauma, type of chest ultrasonography operator, or type of CUS probe used, the overall sensitivity of CUS is superior to supine chest x-ray for diagnosing pneumothorax.
The placement of an inferior vena cava filter reduced the rate of pulmonary embolism in patients with deep venous thrombosis and cancer.
An expert panel has released consensus statements, using the Delphi method, on the use of indwelling tunneled pleural catheters for recurrent pleural effusions.
Thoracic organ transplantation remains a viable treatment option in patients with Eisenmenger Syndrome, although these patients are considered higher risk than other potential transplant recipients.
Adults who are physically active have been shown to have a decreased risk of developing a restrictive spirometry pattern after 10 years.
Recommendations by ASAIO on selection and treatment of patients with respiratory and circulatory failure associated with COVID-19 using artificial pulmonary and/or cardiac support.